CUI,Preferred_Concept
C0205225,Primary
C0015127,Etiology aspects
C0276500,Human immunodeficiency virus I infection
C0008059,Child
C0600138,Does play
C1705810,Generic Role
C0282474,Maternal-Fetal Infection Transmission
C0019704,HIV-1
C0205217,Increased
C0035647,Risk
C1514562,Protein Domain
C2825898,Macrophage Inflammatory Protein 1 Alpha measurement
C0150312,Present
C4321351,Low Level
C2349975,Enhance (action)
C0439165,Percent (qualifier value)
C0184661,Interventional procedure
C3711103,"CCR5 protein, human"
C0040722,disease transmission qualifier
C0065661,Mannose Binding Lectin
C1280500,Effect
C0392756,Reduced
C0010654,cysteine
C1709915,Residue
C0332256,Containing (qualifier)
C0205435,First (number)
C1519623,Transmembrane Domain
C0028778,Obstruction
C0598435,Palmitoylation
C1704675,Interaction
C0311403,inhibited
C0001128,Acids
C0031843,physiological aspects
C0332281,Associated with
C1825562,IFITM5 gene
C0003451,Antiviral Agents
C0205177,Active
C0027365,Name
C0185117,Expression procedure
C1518422,Negation
C0033414,Promotion (action)
C0021747,Interferons
C0002520,Amino Acids
C2348205,Similarity
C0033684,Proteins
C1312248,"IFITM1 protein, human"
C1415897,IFITM2 gene
C1415898,IFITM3 gene
C1516144,Calcium Binding
C1707271,Carboxy-Terminal Amino Acid
C0456389,size
C0027610,Bovine coronavirus
C0026383,Molecular Structure
C0028630,Nucleotides
C0017337,Genes
C0444930,End
C0017428,Genome
C0392171,Influenza-like symptoms
C0686747,Well adolescent
C0001675,Adult
C0449450,Presentation
C0582103,Medical Examination
C0205214,Common (qualifier value)
C1705920,Species
C0206422,Human coronavirus
C0205369,Specific qualifier value
C0683325,clinical aspects
C0012652,Disease Outbreaks
C1175175,Severe Acute Respiratory Syndrome
C3694279,Middle East Respiratory Syndrome
C0282250,Case Fatality Rate
C0456178,Microbiology subtype strains
C0041703,United States
C3258203,Study year
C0205172,More
C5204628,Prevalent
C0205082,Severe (severity modifier)
C1514873,Requirement
C0019163,Hepatitis B
C0007634,Cells
C0332464,Widening
C1520023,Virus-Cell Membrane Interaction
C0009450,Communicable Diseases
C0242821,Human body
C0086597,Mediate
C0205410,Sufficient
C0039869,"Thinking, function"
C0332307,Type - attribute
C0042776,Virus
C0014047,Japanese encephalitis virus
C0014052,Tick-Borne Encephalitis Viruses
C0014046,"Encephalitis Virus, Eastern Equine"
C0037170,Sindbis Virus
C0011315,Dengue Virus
C0470187,Availability of
C0025663,Methods
C0442726,Detected (finding)
C0014038,Encephalitis
C0003342,"Antigens, Viral"
C2987476,Exist
C0439064,Numerous
C0003320,Antigens
C0521115,Simultaneous
C0205447,One
C0370003,Specimen
C0022885,Laboratory Procedures
C0014441,Enzyme-Linked Immunosorbent Assay
C0003241,Antibodies
C5139976,CAPTURE
C0869040,use studies
C0086045,Mental concentration
C1514721,Range
C0025874,Metrorrhagia
C0521095,Determined by
C0010357,Cross Reactions
C1511790,Detection
C0868928,Case (situation)
C0041296,Tuberculosis
C0750572,Estimated
C0008115,China
C0032659,geographic population
C1514578,Province
C0681832,Study Purpose
C0038951,Surveys
C1707689,Design
C0242618,Sample Size
C1555715,entry - cluster
C1707391,Choose (action)
C0027361,Persons
C0009462,Community
C0332196,Exclude
C2603343,Study
C0004927,Behavior
C0009458,Communications Media
C1273517,Used by
C0444159,Sputum specimen
C0237629,Frequency of Responses
C0001779,Age
C0681850,Study Subject
C0033105,Statistical Prevalence
C0871208,Rating (action)
C0038056,Sputum
C0037088,Signs and Symptoms
C0030705,Patients
C0562483,Persistent cough
C0347984,During
C4699618,>65 years
C0580836,Old
C0014442,Enzymes
C0684224,Report (document)
C1517892,Links List
C0517627,Infection status
C3540008,various antiinfectives and antiseptics for local oral treatment
C0030660,Pathologic Processes
C0445623,Microorganism
C0039476,Temperature
C0005507,Biological Assay
C0205197,Complete
C0243161,criteria
C0036849,Set (Psychology)
C0162791,Guidelines
C0013227,Pharmaceutical Preparations
C0871161,Property (attribute)
C0205314,New
C4527371,Candidate
C0006784,Calpain
C0332325,Resistant (qualifier value)
C3827682,Useful
C1533734,Administration procedure
C1328819,Small Molecule
C0011209,Obstetric Delivery
C0027428,Structure of mucous membrane of nose
C0565867,delivery method
C0004048,Inspiration function
C0205170,Good
C1555307,promise
C1515655,In Vivo
C1967611,Dry Powder Inhaler (device)
C1099354,"RNA, Small Interfering"
C1705822,Transfer Technique
C0205373,Systemic
C0678594,Structure
C0348078,Qualitative form
C0086418,Homo sapiens
C0178987,Artificial Airways
C0030608,Particle Size
C0205393,Most
C1280519,Effectiveness
C0441994,Lower - spatial qualifier
C0012634,Disease
C0598496,Gene Silencing
C0024109,Lung
C0205166,Long
C0079941,Open Reading Frames
C1551058,are unit of measure
C1522666,Closest
C0017390,"Identity, Genetic"
C0181758,Surgical face mask
C0042497,Mechanical Ventilator
C1444637,In the past
C0947630,Scientific Study
C0016538,Projections and Predictions
C1615608,Pandemics
C1956259,Acronyms
C1511545,Critical
C1521761,Factor
C0014499,Epidemic
C0043237,World Health Organization
C5203676,2019 novel coronavirus
C0034019,public health medicine (field)
C0029341,Orthomyxoviridae
C0205396,Identified
C0035168,research
C0037179,Unmarried person
C0683920,attack rate
C0205210,Clinical
C0580264,H1N1
C5203670,COVID-19
C0087153,Ventilator - respiratory equipment
C1629517,Exhaled breath condensate (substance)
C0521026,Viral
C1707478,Conclusion
C0225386,Breath
C0332283,Followed by
C0035380,Reverse Transcription
C1261552,Step (specific stage)
C0002778,Analysis of substances
C0422392,Screening Method
C0332152,Before
C0007465,Cause of Death
C3844033,Child 1
C0332177,Monthly (qualifier value)
C0237753,Numbers
C0747676,pneumonia childhood
C0011065,Cessation of life
C0678226,Due to
C0032285,Pneumonia
C0231335,Childhood
C0205448,Two
C2981279,Decade
C0301630,Reduction (chemical)
C4281574,Much
C0021162,Income
C0205251,low
C0227972,Structure of median lobe of prostate
C0454664,Country
C1709305,Occur (action)
C0205101,Extrinsic
C0019994,Hospitals
C0205250,High
C0332282,Following
C0018684,Health
C0442805,Increase
C0035204,Respiration Disorders
C1522427,best (quality)
C1273518,Responsible to
C0034599,Radiology Specialty
C0042196,Vaccination
C1527075,Revision procedure
C1550452,definition - ActMoodCompletionTrack
C0021149,Incidence
C0014009,Empyema
C0332185,Recent
C0439849,Relationships
C0549646,chest disorders
C0027552,Needs
C0034571,roentgenographic
C0042210,Vaccines
C0043167,Pertussis
C0020964,Immunity
C0021270,Infant
C0205216,Decreased
C0035648,risk factors
C0001873,Air Pollution
C1551362,coverage - financial contract
C0021400,Influenza
C0042200,Influenza vaccination
C0233324,Term Birth
C0521530,Lung consolidation
C1552738,described
C0011900,Diagnosis
C1881534,Make - Instruction Imperative
C0016627,Influenza in Birds
C0749385,threat
C0683368,Symptoms aspect
C0087111,Therapeutic procedure
C0439801,Limited (extensiveness)
C0814225,Benefit
C0205234,Focal
C0521116,Current (present time)
C0683954,research results
C0032594,Polysaccharides
C0032098,Plants
C0301872,Immune response
C0039798,therapeutic aspects
C0038952,Continuance of life
C0339901,Acute respiratory infections
C0597404,Respiratory viruses
C0004611,Bacteria
C0013203,Drug resistance
C0332148,Probable diagnosis
C0183319,Sinks
C0332261,Spreading (qualifier value)
C0450254,Pathogenic organism
C0542559,contextual factors
C0457463,types of infections
C0183185,Screens (device)
C3179032,Multiplex Polymerase Chain Reaction
C1706214,Creation
C0033213,Problem
C0039421,Technology
C3494260,Inventions
C0009013,Clone Cells
C1710548,Unique
C0030551,parent
C0441712,Mechanism (attribute)
C0441513,Surgical construction
C0243107,development aspects
C0332149,Possible
C0004561,B-Lymphocytes
C0521114,Infrequent
C5197773,Broadly Neutralizing Antibodies
C1269765,Assisted (qualifier value)
C0597634,Vaccine Development
C0032214,Play
C0024530,Malaria
C0199176,Prophylactic treatment
C3698360,Middle East Respiratory Syndrome Coronavirus
C0205409,Isolated
C0079399,Gender
C0035243,Respiratory Tract Infections
C0449416,Source
C0003062,Animals
C0549183,Midline (qualifier value)
C1301931,Time of death
C0439531,per period (qualifier value)
C0027362,Human Age Group
C3714514,Infection
C1579410,Nucleoside Analogs
C0013216,Pharmacotherapy
C0045093,gemcitabine
C0332454,disrupted
C0243052,Virus Physiological Phenomena
C0034695,"Rats, Cotton"
C0750591,consider
C0599779,Animal Model
C0167627,CD40 Ligand
C3887583,"CD40 Ligand, human"
C0011306,Dendritic Cells
C0042774,Virus Replication
C0017262,Gene Expression
C2741673,Account number:Identifier:Point in time:^Patient:Nominal
C0205419,Variant
C5197798,Codon Usage
C0175566,Open
C0034754,Reading (activity)
C0041912,Upper Respiratory Infections
C0149725,Lower respiratory tract infection
C4330475,Immune Cell
C0439663,Infected
C0567416,Molecule
C0039194,T-Lymphocyte
C0871261,Response process
C0042769,Virus Diseases
C4055506,Accumulation
C0031307,Phagocytes
C0424575,General health
C0205117,Adjacent
C0599883,Trait
C0019196,Hepatitis C
C0205322,Persistent
C0443252,Long-term
C0524910,"Hepatitis C, Chronic"
C0582147,At risk of infection
C0935562,neonatal period
C0036310,Scheuermann's Disease
C0966897,hepcidin
C1880355,Discover
C0178784,Organ
C0030685,Patient Discharge
C0013879,Elements
C0025519,Metabolism
C0600688,Toxic effect
C0302583,iron
C0043227,Work
C0013303,Duodenum
C0024432,macrophage
C1442948,"Plumbum metallicum, homeopathic preparation"
C0242606,Oxidative Stress
C0549193,Parameter Value
C0079809,Measures
C0003402,Antioxidants
C0441889,Levels (qualifier value)
C0014077,"Leukoencephalitis, Acute Hemorrhagic"
C2607943,findings aspects
C0299456,ran-binding protein 2
C1855020,Acute necrotizing encephalopathy
C0032930,Precipitating Factors
C1838681,Rapidly progressive
C0230370,Structure of right hand
C0427053,Weakness present
C0205198,Compound
C1442460,3 Hours
C1301820,Obtain
C0439178,percent positive cells
C0392366,Tests (qualifier value)
C4698447,Patient age
C0086582,Males
C4061114,Acute illness
C0521346,respiratory
C0728836,young child
C1258014,Human Metapneumovirus
C0206545,Human respiratory syncytial virus
C0035236,Respiratory syncytial virus
C0549177,Large
C0017429,"Genome, Human"
C1625778,Human metapneumovirus genotype
C1079230,Subgroup A Nepoviruses
C0205103,Intermediate
C0022558,Kenya
C0025320,Menopause
C0441835,Group A (qualifier value)
C1550040,Control specimen
C0275524,Coinfection
C2986911,Nonclinical Study Length
C0332183,Frequently
C0220905,regulatory
C0392747,Changing
C0036945,Sheep
C1633987,Flock
C3898777,Important
C0850774,infection risk factor
C0205436,second (number)
C0007328,Case-Control Studies
C1711350,Interquartile Range
C0243148,control aspects
C0085973,Case Study
C0441471,Event
C0034362,Q Fever
C0010240,Coxiella burnetii
C0442537,Reservoir (environment)
C3714634,Biological Processes
C0444706,Measured
C1511726,Data
C0332257,Including (qualifier)
C0183652,String (device)
C0242356,Databases
C3539073,In the Field
C0146196,toltrazuril
C0730322,Multiple Evanescent White Dot Syndrome
C0449572,Virus type
C0205473,Serologic
C0039593,Testing
C0449570,Test type
C0205615,Well Differentiated
C0029134,Optic Neuritis
C0441621,Sampling - Surgical action
C0879240,Nasal Swabs
C0028075,Nigeria
C0680022,member
C0205169,Bad
C2828008,Burden
C0011750,Developing Countries
C0680220,majority
C0205392,Some (qualifier value)
C1512456,High Prevalence
C4699345,Coronavirus OC43
C1478824,Human coronavirus NL63
C1744103,OC 229
C1997894,Clinical trial participant (person)
C0002424,Ambulatory Care Facilities
C3494318,Public Health Surveillance
C1704243,Greater
C0683572,Adult Children
C3538928,Usual
C1442461,3 Months
C0231337,Senility
C0012751,Distance
C1539372,EXOSC10 gene
C0525037,CDKN2A gene
C0087186,Irish race
C0376247,Japanese language
C3686947,Equine coronavirus
C0206419,Genus: Coronavirus
C0162326,DNA Sequence
C1705535,suggestion
C0042333,Variation (Genetics)
C0031237,pertussis vaccine
C1114743,Type:ID:Pt:Vaccine:Nom
C0034866,Recommendation
C0183753,Swab specimen
C0444505,Peak level
C3272598,WHO Temperature/Humidity Storage Condition
C0521091,Confirmation of
C0022882,Laboratory Infection
C0884358,Performed
C2584313,Discussion (communication)
C0034036,Publications
C1414444,ERN1 gene
C0013534,Echovirus
C0006754,California
C0025289,Meningitis
C0680240,Agreement
C0009219,Coding
C0035585,Rickettsia Infections
C0022877,Laboratory
C0017446,Geographic Locations
C0014378,Enterovirus Infections
C0206588,"Receptors, Nuclear"
C0006826,Malignant Neoplasms
C0011847,Diabetes
C1290884,Inflammatory disorder
C0029456,Osteoporosis
C0005515,Biological Factors
C0015576,Family
C0027496,Nauru
C1883220,Superfamily
C0679209,prerequisite
C1521991,Molecular
C0442632,Boat dock
C0336791,"Tool, device (physical object)"
C0450363,Three-dimensional
C0175168,"Protein, Organized by Structure"
C0206755,"Crystallography, X-Ray"
C0332218,Difficult (qualifier value)
C1516695,Collected
C1292744,Specimen procedure
C0015733,Feces
C1514811,Bibliographic Reference
C1444754,Length
C0178827,replicase
C0684010,Rabbi
C0205296,Natural
C3178847,Genome Size
C0017011,Gamma Rays
C0439097,Delta - greek letter
C0205309,Known
C0023981,Longitudinal Studies
C0085306,Feline infectious peritonitis
C0085305,Feline infectious peritonitis virus
C0936087,"Coronavirus, Feline"
C0007450,Felis catus
C0680243,controversy
C1282914,Surrounding (qualifier value)
C0071500,polyacrylamide gels
C0314672,Polymerization
C1145667,Binding action
C0237897,Physical Strength
C2266933,Neuraminidase Inhibitors [MoA]
C1521840,Target
C0876173,Tamiflu
C0201622,Cytotoxicity assay
C3895557,inhibition of viral replication
C0200932,Nucleic Acid Amplification Tests
C0443288,Restricted
C0220825,Evaluation
C0597198,Performance
C0336757,"Heater, device"
C0019682,HIV
C1822658,GORAB gene
C0589120,Follow-up status
C0459958,HIV screen
C0237913,Statistical Test
C1707455,Comparison
C0439828,Variable (uniformity)
C0521093,Confirmed by
C1522712,Recombinant Interferon-alpha Inducible Protein 10
C0237881,Statistical Significance
C0038410,Streptococcus pneumoniae
C0876973,Infectious Lung Disorder
C0018704,Health care facility
C0206171,Community-Acquired Infections
C0086965,Selection for Treatment
C0343401,MRSA - Methicillin resistant Staphylococcus aureus infection
C0015686,"Fatty Acids, Essential"
C1285529,Purpose
C0006764,Callithrix
C1155328,Antiviral Response
C1335439,Polymerase
C0243077,inhibitors
C0043266,Writing (occupation or discipline)
C1511481,Consent
C0035668,RNA
C0728990,Clinical Use Template
C0043194,Wiskott-Aldrich Syndrome
C0443286,Reaction
C0439962,Mixture
C1514727,Ras Inhibitor
C1555721,Substitution - ActClass
C0439851,Direct type of relationship
C0026882,Mutation
C0035691,RNA Viruses
C0031254,Pestivirus
C0004793,Base Sequence
C0004390,Autonomous Replication
C0582263,Structural protein
C4553150,BAC Regimen
C0006556,"DNA, Complementary"
C0525038,Amino Acid Substitution
C0282416,Overall Publication Type
C0018696,Health Care Systems
C4045987,Never Event
C0242456,Policy
C0565990,Medical center
C0449295,Limitation
C3161035,Model
C0318855,Porcine epidemic diarrhea virus
C0221423,Illness (finding)
C1292711,part of
C0439855,Complex
C0003755,Arenaviridae
C2700280,World
C0019094,Tacaribe Complex Viruses
C0007589,Cell Differentiation process
C1320226,Incubation period
C0206497,Arenavirus
C0086143,Diagnostic tests
C0036667,Statistical sensitivity
C0874161,oseltamivir
C0216660,zanamivir
C0061751,glycyrrhizic acid
C1705313,Term (lexical)
C0030657,Pathogenicity Aspects
C0444504,Statistical mean
C0449238,Duration (temporal concept)
C0040223,Time
C1517320,From
C4086921,Unilobular
C0332448,Infiltration
C4510762,Human adenovirus 55
C0039985,Plain chest X-ray
C1280464,Manifestation of
C0205263,Induce (action)
C0035222,"Respiratory Distress Syndrome, Adult"
C0887950,Genomics
C1320528,Time of symptom onset
C0013404,Dyspnea
C0583239,Admission to intensive care unit
C0231832,Respiratory rate
C1720176,Upon - dosing instruction fragment
C0184666,Hospital admission
C0023508,White Blood Cell Count procedure
C0233426,Personal appearance
C1550335,Patient type
C0277876,Pulmonary sign AND/OR symptom
C0871685,Clinician
C1706701,Acquisition (action)
C2347029,Biospecimen Type
C1515187,Take
C0444137,Specimen from endotracheal tube
C1513040,Measurable
C0042749,Viremia
C0005810,Blood Group (classification)
C1062667,Human mastadenovirus A
C0026565,Mortality Vital Statistics
C1167909,T lymphocyte count
C0597535,Success
C1524063,Use of
C2349751,Invasive positive pressure ventilation
C0001487,"Adenovirus Infections, Human"
C0936012,Analysis
C0694549,Community acquired pneumonia
C0701159,Patient in hospital
C0439234,year
C0150872,chest findings
C2062441,Influenza A
C1442160,Cutoff
C1522609,Numerical value
C0474643,Antibody titer measurement
C0475208,Titer
C0459471,Interpretation Process
C1517741,Last
C1947946,Aim (idea)
C0150775,Social Networks
C0359589,Provide (product)
C1516606,Clinical Data
C0016674,France
C0325552,Lammergeier
C0086287,Females
C1516232,Cancer Survivorship Research
C0038954,Survival Rate
C0543482,morphological
C0282639,HT29 Cells
C1947931,Direct (qualifier)
C0521447,Nuclear (nucleus)
C0233656,Mental condensation
C0162638,Apoptosis
C0449475,cell type
C3900053,Amenable
C0007102,Malignant tumor of colon
C0018017,objective (goal)
C0015852,Fermentation
C0017982,glycosylation
C1521970,Characteristics
C3154893,Possess
C0596577,Flavonoids
C1451210,"FGL2 protein, human"
C0019185,Murine hepatitis virus
C1518614,Organism Strain
C0302809,Fulminant Hepatitis
C0040048,Thromboplastin
C1414609,FGL2 gene
C0005778,Blood coagulation
C0586688,Tissue specimen from liver
C1883727,Taken
C1281905,At risk of disease
C0442529,Urban environment
C0870781,Landscapes
C1160716,viral transmission
C0032850,"Fowls, Domestic"
C0033268,production
C0443193,Convergence - direction
C1511253,Boost
C0034980,Regression Analysis
C0040811,Trees (plant)
C2248788,4-hydroxy-2-ketopimelate aldolase activity
C0332167,High risk of
C0814835,land use
C0332472,abnormal fragmented structure
C0035567,Rice (Dietary)
C1263424,LYSP100-associated nuclear domain
C0008051,Chickens
C0600653,Indexes
C0242781,disease transmission
C0021135,In Vitro [Publication Type]
C1705968,Cartridge Dosing Unit
C0020336,hydroxychloroquine
C0008300,Choice Behavior
C0521125,Preposition For
C1522326,Treating
C0008269,chloroquine
C4726677,remdesivir
C0031327,Drug Kinetics
C0678723,Biologic Development
C0014139,Endocytosis
C3887511,Evidence
C0003209,Anti-Inflammatory Agents
C0010340,Critical Illness
C0032105,Plasma
C0079189,cytokine
C1709707,Proportion
C0018724,Health Personnel
C0086132,Depressive Symptoms
C0860603,Anxiety symptoms
C0917801,Sleeplessness
C0231303,Distress
C3483978,Anxiety score
C4706228,ISI (Insomnia Severity Index) score
C0451226,Impact of event scale
C0449820,Score
C1274040,Result
C0037773,"Spastic Paraplegia, Hereditary"
C1838626,Cerebral malformations
C0004352,Autistic Disorder
C1428695,KATNAL1 gene
C0683212,central nervous system function
C0026649,Movement
C0025914,House mice
C0193959,Tonsillectomy and adenoidectomy
C0083355,amsacrine/azacitidine/etoposide
C0014057,Japanese Encephalitis
C0205224,Essential
C0065656,manidipine
C1705242,Different
C0086282,Family member
C0016215,Flavivirus
C4277569,Protein Structural Elements
C0815043,"Protein, Organized by Function"
C0872187,High Throughput Screening
C1514798,Recombinants
C2717802,Viral Structures
C3245505,Potential
C0035870,Rotavirus
C1979882,Double strand
C0032520,Polymerase Chain Reaction
C0443211,Established
C0442886,Secondary Infections
C0021017,Immunoglobulin Isotypes
C0034865,"Recombination, Genetic"
C5206618,Somatic Hypermutation
C0725813,depend
C1709793,Quantitation
C1265611,Quantity
C0074257,secretory IgM
C4698719,Confirmed case
C2584321,Reaching
C3830166,February
C0014003,Employment
C1553874,Concept Status - Proposed
C0679006,Decision
C0027855,Neurology speciality
C0026339,Biological Models
C0456984,Test Result
C0424972,Member of large family
C1704711,Distribution
C0231193,adaptive
C0085104,Drug Delivery Systems
C4048755,Apply
C0185125,Application procedure
C0018790,Cardiac Arrest
C0002045,algorithm
C2698650,Optimization
C0439659,Beginning
C3812881,Author
C0379099,vacuolar H+-ATPase
C0001473,Adenosine Triphosphatases
C1704241,complex (molecular entity)
C2338615,Plasma membrane of osteoclast
C0806036,Renal epithelial cell
C0302600,Angiogenic Process
C0332155,Did not receive therapy or drug for
C0000379,"3,4-Methylenedioxyamphetamine"
C1708632,Labeled (qualifier)
C0805586,Challenge
C1273870,Management procedure
C0619485,A 19
C0814435,early identification
C0274281,Injury due to exposure to external cause
C0442804,Very high
C0021708,intensive care unit
C1882442,Precaution
C0038215,Science of Statistics
C0681842,Prediction
C0449738,Direction
C0042587,Vesicular stomatitis Indiana virus
C0027763,Nervous system structure
C1707489,Connectivity
C0599854,neuronal circuitry
C0007289,carrageenan
C0557702,Window (physical object)
C0005595,Aves
C3658219,"Influenza A Virus, H7N9 Subtype"
C0856238,influenza (epidemic)
C0332181,Annual
C0443254,Mechanical Methods
C0237820,Recovery - action
C0004083,Mental association
C0308779,DELIVER (veterinary product)
C0449560,Subtype (attribute)
C2076600,Influenza due to Influenza A virus subtype H1N1
C0009649,"Conditioning, Classical"
C1883357,Together
C0439093,Greater Than
C4763675,Single Agent Therapy
C1704788,Definition
C1527178,Basis - conceptual entity
C0150105,Random Sampling
C0439601,Seasonal course
C1705241,Delta (difference)
C0035373,Reunion Island
C4279933,Vaccination Campaign
C0005532,biology (field)
C0220920,surveillance aspects
C0206243,Carrying
C0439787,Out (direction)
C0205160,Negative
C2985627,Study Objective
C0036497,Seasons
C0040833,trends qualifier
C0005775,Blood Circulation
C4267729,Respiratory pathogens
C0205171,Singular
C0241301,Summer
C0241737,Winter
C1512571,Hypothesis
C0543488,Interested
C0392760,Affecting
C3843933,Feb.
C0034927,Patient referral
C3539897,Have
C0325069,"Palm civet, NOS"
C0237876,Sharing (Social Behavior)
C0008139,Chiroptera
C0750558,Unlikely
C0220912,Aspects of signs
C0332253,Evolving
C0015219,Biological Evolution
C0349590,Nature
C4518065,Paper report
C0332268,Lacking
C0036397,Science
C1175743,SARS coronavirus
C3146294,Generation (action)
C0598312,DNA Replication
C0543483,pathogenic aspects
C1518039,Mouse Lung
C0332161,Attenuated by (contextual qualifier)
C0205173,Duplicate
C0427861,Human cells
C0524523,Civets
C4086523,Intermediate Host
C4761558,Salar Chinese
C0085732,Ability
C1167395,Host (organism)
C2603360,T prime
C0681814,research study
C0008109,Chimera organism
C0205087,Late
C0183683,"Support, device"
C1441547,Derivation
C0871282,rumors
C1708698,Light Emitting Diode Device
C0031831,Physicians
C0205265,Initially
C0598279,synthetic construct
C0205319,Manifest
C0011991,Diarrhea
C0260319,Virologists
C0017431,Genotype
C0019092,Hantavirus
C0456603,Ratio
C0449943,Serotype
C0814777,caseload
C0243025,Hantavirus Pulmonary Syndrome
C2699424,Concern
C0402112,Scientist
C0032667,Population Dynamics
C0181586,Leads (device)
C0043528,Zoonoses
C1707959,Example
C0556581,Retinol equivalents
C4760114,Century (brand of cigarette)
C0682447,virus by host
C0700321,Small
C0024660,Mammals
C0242994,Hantavirus Infections
C0002454,Americas
C0553534,Cardiopulmonary
C0039082,Syndrome
C0018787,Heart
C0282443,Review [Publication Type]
C0008120,Chinese Language
C1843013,"Alzheimer disease, familial, type 3"
C0443289,Revealed
C0019101,Hemorrhagic Fever with Renal Syndrome
C0332302,Brought on by
C0004268,Attention
C1879848,Biomedicine
C0086384,Hantaan virus
C1708235,Genus
C1882932,Representation (action)
C0008902,Classification
C0006395,Bunyaviridae
C0449719,Part
C0332437,Morphology
C1415375,GYPC gene
C1522240,Process
C1160692,virus maturation
C0010813,Cytokinesis
C0700364,Appearance
C1710082,Signal
C0018381,Guinea (geographic area)
C3537453,GBA wt Allele
C3245499,Colombia
C0597357,receptor
C0017968,Glycoproteins
C4684849,Presumed
C0023688,Ligands
C4722602,Underlying
C1997138,Blunted
C1552551,Any
C0030664,Pathology
C0035696,"RNA, Messenger"
C0065827,Measles Virus Nucleoprotein
C0085177,RNA-Binding Proteins
C1517520,Genomic Segment
C0079613,Adoptive Immunotherapy
C2712604,Other activity
C0369718,N not otherwise specified Antibody
C0035736,"RNA, Viral"
C1880165,Concentrate Dosage Form
C0242842,"Microscopy, Confocal"
C0205474,Biochemical
C1999216,Inhibitor
C0040594,Track (course)
C0079220,Destination
C0282629,Virus Assembly
C3840880,Traffic
C1512032,Dominant-Negative Mutation
C0332147,Suspected diagnosis
C0007952,Personality Character
C0015376,Extravasation
C2346874,Attractive
C0040300,Body tissue
C0036563,Plant seeds
C1705192,Seeding
C0205276,Local
C0014257,Endothelium
C1184743,bony process
C1947971,Give - dosing instruction imperative
C4321377,Relational and Item-Specific Encoding Task
C0027627,Neoplasm Metastasis
C0309049,favor
C0442893,Systemic disease
C0000768,Congenital Abnormality
C1998882,Sometimes
C0681841,Explanation
C0035173,Research Personnel
C1382398,Increased capillary permeability (finding)
C0231221,Asymptomatic
C0018557,Hamsters
C0687676,Post
C0026018,Microscopy
C0052432,artesunate
C0887913,Andes Virus
C0036572,Seizures
C0026429,"Monitoring, Physiologic"
C0015272,Exhibits as Topic
C0232132,Weak arterial pulse
C0039231,Tachycardia
C0020649,Hypotension
C0205449,Three
C1707520,Correlation
C0442335,Vectors
C0680536,commercial
C0597420,Salmonella Vaccines
C0050325,A-factor (Streptomyces)
C0597641,plasmid vaccine
C2347662,Pre-existing
C0012656,Disease Vectors
C0521009,Bacterial
C1517378,Gain
C0014834,Escherichia coli
C0064582,lactic acid
C0023859,Listeria
C1520007,Viral Vector
C0023636,License
C1331096,vaccine delivery
C0449379,Connection
C0036111,Salmonella
C0032868,Poxviridae
C0001483,Adenoviruses
C1709854,Recipient
C0020966,Cellular Immunity
C4321235,OCA2 wt Allele
C0332289,Transmitted by
C0004595,Bacillus subtilis
C1527415,Oral Route of Drug administration
C0021853,Intestines
C0442027,Oral
C0020971,Immunization
C0449432,Component object
C0596638,Gut associated lymphoid tissue
C0021839,Intestinal Mucosa
C1706912,BARRIER
C0282557,"Immune Response, Mucosal"
C0021212,Indicators
C0021753,"interleukin-1, beta"
C0422202,Notifications (procedure)
C0008848,Cities
C0020029,"Hospitals, Urban"
C1707059,Pre-release version of a computer program
C0205374,Transitory
C0679238,disease factor
C0034037,Publishing
C1857276,Trichohepatoenteric Syndrome
C3179065,Social Media
C1533716,Information
C0018721,Health Workforce
C0231175,Failed
C0700382,"Washing hands, function"
C1444641,At risk
C0018563,Hand
C0332197,Absent
C0205091,Left
C0040802,travel
C0029347,influenza A virus
C1517050,Extracellular Domain
C0378910,Lymphocyte antigen CD66A
C0597298,Protein Isoforms
C2352715,"CEACAM5 protein, human"
C0282625,src-Family Kinases
C0018896,Helping Behavior
C0449297,Clearance
C1326212,neutrophil apoptotic process
C0022688,Natural Killer Cells
C0424324,Fighting
C0870509,Escape (mental process)
C2611765,KILLER binding
C0537439,enfuvirtide
C0332575,Redness
C0522501,Massive
C1260957,Blue color
C0332583,Green color
C0332585,Pink color
C0205341,Repeat
C4699623,High activity
C3463820,Inhibition
C2981707,Stage IIB Uveal Melanoma AJCC v7
C1535502,Bronchoalveolar Lavage
C0229671,Serum
C0018517,Half-Life
C0201734,Pharmacokinetic study
C1979963,Profile (lab procedure)
C1707995,FABP4 wt Allele
C2348397,Elimination Half Life
C0439095,Greek letter alpha (qualifier value)
C0026377,Molecular Conformation
C5203671,Suspected COVID-19
C0017160,Gastroenteritis
C0949920,Norovirus
C0152517,Viral gastroenteritis
C0884118,adenovirus type
C0040284,Tissue culture
C0695341,common procedures
C0175671,Universal
C0206415,Oligonucleotide Primers
C1273421,Viral studies (procedure)
C0205437,Third
C0444868,All
C0428210,Methionine measurement
C1272460,Not Applicable
C0475463,"Antibodies, Neutralizing"
C0679058,encoding mental process
C1445860,Protein antibody
C4264487,Type A
C0023756,Panthera leo
C0015176,Europe
C3494191,Phage Display Techniques
C0004651,Bacteriophages
C0007294,Genetic Carriers
C0008679,Chronic disease
C0205272,Regular
C0042760,Virion
C1423498,GOLPH3 gene
C1113686,directed evolution
C0206397,Inovirus
C0206398,Plectrovirus
C0023621,Libraries
C1564139,Mutant Proteins
C0562342,Empowered
C1623051,Filamentous bacteriophage (species)
C1705417,Device Display Device
C1513371,Mode
C0205543,Referring
C0231448,Extension
C0205148,Surface
C0003316,Epitopes
C0599934,"Vaccines, Peptide"
C0002111,Allergy Specialty
C0005525,Biological Response Modifiers
C0282115,"Vaccines, Contraceptive"
C0030956,Peptides
C0302891,Native (qualifier value)
C0003261,Antibody Formation
C0001551,Immunologic Adjuvants
C0021494,Intravenous Injections
C5142938,Merit
C0016884,Future
C0018282,Growth Inhibitors
C0038172,Staphylococcus aureus
C0008168,chloramphenicol
C0162388,Killing
C0334227,"Tumor cells, malignant"
C0027651,Neoplasms
C0870432,Display - arrangement
C1883036,Single-Chain Antibodies
C1449651,Amyloid Fibrils
C0030567,Parkinson Disease
C0597177,Particle
C1512612,Ideal
C0337143,Scaffold
C0008976,Clinical Trials
C1450053,Nanostructured Materials
C3687625,Demonstrates
C1292732,Investigates
C0849355,Removed
C4727198,Read Length
C0337797,Belgians
C0039005,Family suidae
C1216700,Kobuvirus
C0079134,Clostridium difficile
C2613267,sporulation
C0182953,Regulators (device)
C1136170,Virulence Factors
C0030695,Patient Monitoring
C1171362,protein expression
C0014049,Venezuelan equine encephalitis virus
C0162327,RNA Sequence
C1515877,activate biological process
C1155342,cellular response to unfolded protein
C1704259,Biochemical Pathway
C0042153,utilization qualifier
C0162847,protein folding
C1327616,Cell secretion
C1414314,EGR1 gene
C2982691,Reside
C3258060,Primary sign and symptom
C0242488,Acute Lung Injury
C0310255,survive
C0205404,Serious
C1705654,Entry (data)
C3845593,Major change
C0242656,Disease Progression
C0020962,Immune system
C0036658,Esthesia
C0033325,Forecast of outcome
C0145943,TimeLine Fluoride Releasing Resin
C0021743,Interferon Type I
C0042736,Viral Proteins
C0239126,corticosteroid use
C0870668,hospitalized patients
C0678889,Immunoregulation
C0012920,"DNA Topoisomerases, Type I"
C0009521,Complement C5a
C0360714,Hydroxymethylglutaryl-CoA Reductase Inhibitors
C0199168,Medical service
C0009488,Comorbidity
C0021054,Immunologic Factors
C0220901,prognostic
C0005516,Biological Markers
C0748355,Acute respiratory distress
C4086878,Symptom Onset
C2806453,Betacoronavirus
C0079946,National origin
C1552603,search - EntityNameUse
C1522168,Topical Route of Drug Administration
C1706202,Search - action
C1704970,Means
C0035820,Social Role
C0456204,Specimen type
C0430022,diagnostic procedure
C3539922,Loop-mediated Isothermal Amplification
C0599161,Reverse Transcriptase Polymerase Chain Reaction
C0036743,Serologic tests
C1627358,Refractive surgery enhancement
C1514863,Reproducibility
C1709846,Real-Time Polymerase Chain Reaction
C0812225,Kit device
C0205450,Four
C0036043,Safety
C1514821,Registration
C0449438,Status
C0205455,Nine
C4042908,Seroconversion
C1441672,Observed
C0549178,Continuous
C0206034,"Clinical Trials, Randomized"
C0035363,Retrospective Studies
C0920321,Phase I Clinical Trials
C0456962,Rapid
C0017296,gene therapy
C0085415,Treatment outcome
C0680218,superiority
C0458579,Lower respiratory tract structure
C1547923,"Aspirate, Tracheal - specimen source code"
C2945599,Mild (qualifier value)
C0458578,Upper respiratory tract
C0237607,Practice Experience
C0440471,Genetic Materials
C0007610,Cell Nucleus
C0558295,preference
C0002928,Spinal Anesthesia
C0686750,Well adult
C1271650,Antimicrobial activity
C0085236,"Macrophages, Alveolar"
C0071313,"plY protein, Streptococcus pneumoniae"
C3151529,Lethal
C0376435,Random Peptide Library
C0022940,Lactobacillus casei
C0008356,Cholera Toxin
C4050014,Unknown GENC
C0087113,Treatment Effectiveness
C0236493,Influenza antibody
C0231290,Status post
C0439231,month
C0042212,"Vaccines, Inactivated"
C1704640,Matrix Array
C0457242,square metres
C0021403,Influenza virus vaccine
C3242229,ineffective
C1210581,Lactobacillales
C0449914,Delivery system
C1330623,Live Influenza Vaccines
C1709450,Pair
C1327414,cytokine secretion
C1424250,NLRP3 gene
C2936529,Inflammasomes
C0022009,Ion Channel
C1979975,Single strand
C3828767,November
C3829447,July
C0035690,RNA Virus Infections
C0599561,e protein
C0205431,Formed
C0018188,Granuloma
C1168005,Alpha tumour necrosis factor measurement
C1150579,MAP kinase activity
C0752312,Mitogen-Activated Protein Kinases
C1879547,Activation action
C1314939,Involvement with
C0031715,Phosphorylation
C1956001,Mitogen-Activated Protein Kinase Phosphatases
C0023810,Lipopolysaccharides
C0282655,Critical Pathways
C1523987,Alternative
C0439858,Conventional
C0205246,Generalized
C1534709,Splitting
C5206843,FDA Inactivation
C0770694,trivalent influenza vaccine
C1521801,Having administered
C1721019,Virus Attachment
C0150110,gold standard
C0332287,In addition to
C0392360,Indication of (contextual qualifier)
C1545588,Protection
C3272757,Live Attenuated Influenza Vaccine
C0005903,Body Temperature
C1456404,Trivalent Live Attenuated Influenza Vaccine
C1269955,Tumor Cell Invasion
C0036576,Genetic Selection
C1709269,North
C0035139,Surgical Replantation
C0086960,Schedule (document type)
C1999230,Providing (action)
C0442818,Raised
C0012931,Recombinant DNA
C1627932,Adenovirus serotype
C1510800,Adenovirus Vector
C1552907,Adenovirus Vaccine
C0991533,Oral Capsule
C0231174,Failure (biologic function)
C0521819,Vaccination failure
C0007637,Inclusion Bodies
C0814942,Han Chinese
C4054739,Immunogenicity Study
C1524062,Additional
C0679199,Strategy
C4709333,Adeno-associated Virus Vector
C1564874,Adeno-Associated Virus
C0002331,Alphavirus
C0035142,Replicon
C0680651,appeal
C0010825,Cytomegalovirus
C0333785,Virus-like particles
C0079005,Baculoviridae
C4055445,Approved for Human Use Product
C0184511,Improved
C2986815,Robust
C0020969,"Immunity, Innate"
C0027984,Newcastle disease virus
C0332306,Quality
C0917903,Conclude Resin
C1143949,"TNFSF10 protein, human"
C0026809,Mus
C1549081,Termination - Inactive Reason Code
C0042207,Vaccination against smallpox
C0042214,Vaccinia
C0376649,Addresses (publication format)
C0586139,Influenza vaccination status
C2349186,Fit (action)
C0439617,Revision
C0443318,Sustained
C0025260,Memory
C0007613,Cell physiology
C0039341,tat Protein
C0560560,Moving
C0007609,Cell Nucleolus
C0035701,Ribosomal RNA
C0035553,Ribosomes
C1179105,Region of fibrillar component of nucleolus
C0521448,nucleolar
C0475264,localization
C0574204,Tatar language
C0017282,"Gene Products, rev"
C1317750,Study report
C0022262,Isotopes
C0181496,Labels (device)
C0003765,arginine
C0024337,lysine
C0010453,Anthropological Culture
C0028589,Nuclear Proteins
C1428200,TIPARP gene
C0002318,alpha-Tubulin
C0039224,Table - furniture
C3715215,S1
C1880833,Fold Change
C4193472,Mammarenavirus
C0035804,Rodent
C0441833,Groups
C0023092,Lassa Fever
C0682523,Human Cell Line
C0018802,Congestive heart failure
C0029904,ouabain
C0449234,Concept Attribute
C0442799,Efficient
C1412628,ATP1A1 gene
C0084178,prohibitin
C1880177,Contribution
C2911648,Multiplication
C1551338,Entity
C0242744,"Earth, Planet"
C1279919,Early
C1550543,Fulfill
C0376558,Life
C0745777,Lost
C0085862,Independence
C0562630,Intracellular parasite
C0080125,Catalytic RNA
C0678595,peptide bond
C0012854,DNA
C0220806,Chemicals
C0332529,Consistency
C0008056,Chikungunya virus
C0008055,Chikungunya Fever
C0023008,Languages
C1824356,RESF1 gene
C1314677,Maintaining (action)
C0001737,Africa
C0003980,Asia
C0222032,Spur (body structure)
C0332174,Weekly
C0022130,Islands
C1522508,Details
C0078988,Asians
C0027567,African race
C0441655,Activities
C0022275,Italian language
C0204727,Isolation procedure
C0439228,day
C0585064,Numerical phases
C0686907,Consequence of
C2734086,Chikungunya virus IgM
C3715206,Eighteen
C0457343,Chronic phase
C1880022,Characterization
C0030193,Pain
C0009566,Complication
C3887670,AE synonym fragment
C0009490,Comoros
C0036919,Seychelles
C0275626,Struck
C0011041,DDT (Insecticide)
C0457083,Usage
C0023031,lanthanum
C4521003,VACUOLAR-TYPE PROTON-TRANSLOCATING ATPase SUBUNIT E1
C0376441,Indian Ocean
C0303920,Fluorescent stain
C1292748,Introduces
C0028405,North America
C0021289,"Infant, Newborn"
C0026591,Mother (person)
C1550608,Instance
C0015965,Fetus
C0242648,Vertical Disease Transmission
C0178795,Perinatal period
C1513895,National Institute of Allergy and Infectious Diseases (U.S.)
C0600091,Identifier
C0808080,STRENGTH (attribute)
C0376613,"Vaccines, DNA"
C1547538,Facility
C1521743,"Monitor, occupation"
C0282687,"Hemorrhagic Fever, Ebola"
C0600109,Willing
C0013480,Ebola virus
C0017313,patient care
C0276472,Avian infectious bronchitis
C0205132,Linear
C1514756,Receive
C1553446,Suite
C0376705,Viral Load result
C1512977,Mammalian Cell
C0441659,Recreational flying
C0449265,Elicited by
C0000934,Acclimatization
C1521738,Field
C2986575,Connect (action)
C1302234,Fatal
C1880266,Defense
C0424295,Hyperactive behavior
C0043012,Wakefulness
C0013621,Knowledge acquisition
C0013126,Intrinsic drive
C0332452,defective
C1516240,Capacity
C0002199,Interferon-alpha
C0427529,Smear cell
C0120285,Green Fluorescent Proteins
C0872351,monolayer
C2349984,Inversion
C0026022,"Microscopy, Fluorescence"
C0870071,Modeling
C0969625,Methodology aspects
C1711343,Deriving
C0552449,Equation
C1522410,Highest
C1301808,Geographic state
C0007320,Case Reports Publication Type
C0007457,Caucasoid Race
C0442519,Home environment
C0439834,Slow
C0376691,Programs - Publication Format
C0750532,MILDLY
C0231218,Malaise
C0205390,Phase
C4745084,Medical Condition
C0699788,Import
C0439157,counts
C2986483,Doubling Time
C0598394,enzootic
C0035242,Respiratory Tract Diseases
C3842296,Else
C0683278,Mental Suffering
C1836348,Severe disorder
C1154657,perception of virus
C1315072,Serology (antibodies and most antigens except blood bank and infectious agents)
C0013849,Email
C0443640,Specific antibody
C0444454,Access
C1883708,Then
C1879743,As Much as Desired
C0014507,Epidemiology
C0205329,Progressive
C0036243,Saudi Arabia
C4288581,Notable
C1272688,status - In progress
C0022773,South Korea
C0449335,Method of detection
C0008903,Taxonomic
C0020792,Identification (Psychology)
C1272318,Presence of virus (procedure)
C0034861,Recombinant Proteins
C0037791,Specificity
C0449445,Approach
C0036745,Study of serum
C0741847,Bypass
C0599220,Protein Subunits
C1136348,Protein Microarrays
C0218063,Ensure (product)
C0885847,human urine
C0162633,Viral Shedding
C1264633,Fraction of
C4036459,Contacts
C0332156,Return to (contextual qualifier) (qualifier value)
C0042295,Values
C0006801,Camels
C4699158,Increased risk
C0027363,Occupational Group
C0018019,Capra hircus
C0349374,Cow's milk
C1698986,Storage
C0439237,degrees Celsius
C0521108,Recovering from
C0443348,Viable
C0428692,Ambient temperature
C0428696,Relative humidity
C3242389,Airborne exposure
C0010200,Coughing
C0001712,Aerosols
C0205108,Distal (qualifier value)
C1444005,Human to human transmission
C1564867,Basic Reproduction Number
C0003671,Arabian Peninsula
C1320717,Respiratory event
C0332232,Approximate
C0730559,Respiratory percentage
C2700400,Contain (action)
C0750489,apparent
C0205394,Other
C0475311,Harbor
C0449435,Manufactured aid
C0443131,Accurate (qualifier)
C1441506,Calculation
C3274649,Probable Case Status
C1710360,Technology Platform
C4330491,Instrumental Activities Domain
C2713449,Information Sharing
C0936234,Computed Tomography Scanning Systems
C0016249,floor (object)
C0040405,X-Ray Computed Tomography
C0024861,Masks
C1280412,Thick
C0934502,anatomical layer
C0020912,Optical Image Reconstruction
C1261322,Evaluation procedure
C0524637,"Recognition, Psychology"
C1704254,Medical Image
C0700287,Reporting
C0202823,Chest CT
C0425382,Personal status - Adopted
C4075962,Low dose computed tomography of thorax
C0678341,Responsibility
C0587500,Radiology department
C0205146,Area
C0332849,Divide
C0205279,Contaminated
C1547703,Room
C1947930,Cleaning (activity)
C0006353,Buffers
C0014672,Equipment
C0031809,Physical Examination
C1319127,Level of stress
C1552089,Staff Member
C1516050,Assignment - action
C0585347,Single event
C1856053,Hydranencephaly with Renal Aplasia-Dysplasia
C0332158,Contact with
C0302523,Observation in research
C1629510,Oral swab (specimen)
C0005767,Blood
C0444214,Anal swab
C0521117,Severity of illness
C0178913,Blood specimen
C1718344,Special care (attribute)
C0439793,Severities
C0205221,Disseminated
C0229960,Entire body as a whole
C0001747,"Africa, Western"
C0013956,Emergency Situation
C1443871,Personal protective equipment
C1956344,Emergency Preparedness
C1185625,Anatomical compartments
C0205421,Deferred
C0019993,Hospitalization
C0206132,Age of Onset
C0039725,Thailand
C0022341,Japan
C3176590,Illness duration
C0545082,Visit
C0275522,Asymptomatic Infections
C3829466,January
C0886414,Body temperature measurement
C0231435,Mobile
C0057717,diamond
C0036971,Ships
C0557989,Restriction of movement
C0205439,Fifth
C1272689,Started
C0332288,Without
C0450048,Passenger
C2350739,rupintrivir
C0276447,Rhinovirus infection
C0544076,"Etiology, primary"
C0004096,Asthma
C0025252,Membrane Proteins
C1135440,Procedures involving the use of pharmaceuticals
C0012655,Disease susceptibility
C0231220,Symptomatic
C0439609,Urgent
C0549179,Priority
C0031082,Periodicals
C1272706,Interval
C4082764,Gastrointestinal infection
C0868963,Gardening
C2708283,Clinical presentation
C1883073,Electromagnetic Spectrum
C0205238,True
C0162340,Comprehension
C1444748,Triggered by
C3266261,One chronic disease
C0702117,consolidated
C0001554,Administration occupational activities
C0231242,Complicated
C1517331,Further
C4086268,Exacerbation
C0743630,exacerbation acute
C0450442,Agent
C0684312,Drivers of Vehicles
C0740304,copd exacerbation
C2828393,Exact (qualifier)
C0220898,Predisposition -- attribute
C2945843,Site of
C0725694,comply
C1542147,Main
C4523782,Inflammatory airway disease
C0233535,Butting
C0547044,Smaller
C0439792,Extent
C1514849,Replication-Associated Process
C0021368,Inflammation
C3898900,Healthy
C0333348,Inflammatory
C0221908,Epithelial
C0149516,Chronic sinusitis
C0027430,Nasal Polyps
C0014457,Eosinophilia
C0024117,Chronic Obstructive Airway Disease
C0441730,Type 2
C0014597,Epithelial Cells
C3263722,Traumatic AND/OR non-traumatic injury
C0034790,T-Cell Receptor
C0007587,Cell Death
C4522252,Foundation for the Accreditation of Cellular Therapy
C2717799,Metagenomics
C0200931,Polymerase chain reaction analysis
C0221099,Impaired
C0242767,Stem of plant
C1268456,Viral Components
C1527428,Remaining
C0021376,Chronic inflammation
C0546816,Persistence
C0281991,steroid use
C1260953,Suppressed
C1567292,"Myosin Phosphatase Rho-Interacting Protein, human"
C1261381,Destructive procedure (surgical)
C0683521,Patient Physiological Condition
C0729531,Viral respiratory infection
C0332271,Worsening pattern
C1290886,Chronic inflammatory disorder
C0578491,Infection by site
C0014406,Environment
C0225377,Structure of upper respiratory tract cavity
C0231202,Symbiotic
C0035235,Respiratory Syncytial Virus Infections
C0026727,Mucous body substance
C0332453,Disruption
C0015422,Eyelash
C1101610,MicroRNAs
C0699949,airway disease
C0014609,Epithelium
C0887909,"RNA, Untranslated"
C0443264,Modulated
C1655731,study of epigenetics
C1444656,Indicated
C0040028,"Thrombocythemia, Essential"
C0202311,Aluminum measurement
C0851901,Rhinovirus infections
C0035473,Rhinovirus
C0206558,Simplexvirus
C0027950,neutrophil
C1515981,And
C1292424,Single point in time
C0542341,Function (attribute)
C0439662,Immune
C2587213,Control function
C0850310,Possessed
C1514568,Protein Truncation
C0018270,Growth
C0022277,Italy
C0043129,Western Europe
C1273869,Intervention regimes
C0442504,Place
C1720302,Until
C0679201,Inference
C1825598,IMPACT gene
C3274659,Model Number
C0035150,Reproduction
C1416797,STMN1 gene
C0034386,Quarantine
C0037412,Social Distance
C0750729,Course
C0454713,European country
C3258257,Total population
C0087130,Uncertainty
C4743675,Impossible
C1321095,Drop Dosing Unit
C0205548,Stat (do immediately)
C0018599,Hardness
C0009847,containment
C1292431,Procedure phase
C0520511,Distributing
C0678257,Description
C0206750,Coronavirus Infections
C1549735,Identifier type - Person number
C1547761,Alert level
C1442162,GIVEN
C0681024,economic impact
C0815353,Male external urethral sphincter
C1272695,Done (qualifier value)
C1310468,"DDX58 protein, human"
C2239342,DDX60 gene
C0015264,Exertion
C0239307,ethnic european
C0599437,Authority
C1273802,Regional office
C0449244,Time of onset
C0015967,Fever
C0230463,Sole of Foot
C1457887,Symptoms
C0332290,Consistent with
C1114752,"Pre-existing physician-diagnosed allergies, birth defects, medical conditions:Finding:Point in time:^Patient:Nominal"
C0032310,"Pneumonia, Viral"
C0449255,Context
C1517927,Locally
C0439661,Acquired (qualifier value)
C0871157,Prompting
C0442732,Vital (qualifier value)
C0682356,Witnesses
C1514537,Protein Biosynthesis Pathway
C1517886,Limited stage (cancer stage)
C0005540,Biomedical Research
C1519614,Genetic Translation Process
C0178566,concept
C0600661,Outlines (document)
C0524669,Coins
C2699488,Resolution
C0001074,Structure of achilles tendon
C0018870,Heel
C1080058,This (eukaryote)
C2936405,Drug Repositioning
C1512888,International
C2828361,Do (activity)
C1413357,CFLAR gene
C0441987,Side
C0084795,Tristetraprolin
C1415638,HNRNPD gene
C1826784,RC3H1 gene
C0035342,Retinol Binding Proteins
C0597415,RNA methylation
C0337076,Industrial machine
C0337108,Brake device
C1514248,Post-Transcriptional Regulation
C1823924,ZC3H12A gene
C0287990,paired basic amino acid cleaving enzyme
C2700640,Encode (action)
C2346714,Abundance
C0872047,high throughput technology
C0681833,Basic Research
C0152036,Immunology
C3658355,CRISPR-Cas Systems
C1881379,Lineage
C0030391,"Parainfluenza Virus 2, Human"
C1366752,Neomycin resistance gene
C0042762,Science of Virology
C0039828,Theses
C1550031,Unlock
C0681473,agenda
C0079816,Medical Research activity
C0439607,Priorities
C3540678,Task
C1522634,Question (inquiry)
C1321919,"TLR4 protein, human"
C0037750,Spanish Language
C0332173,Daily
C1615607,"Influenza A Virus, H1N1 Subtype"
C1707686,Descendent
C0029345,"Orthomyxovirus Type A, Porcine"
C0556970,times/year
C0678544,wave - physical agent
C1135927,"Immunity, Herd"
C0020167,Humidity
C0445247,Same
C0029343,"Influenza A Virus, Avian"
C0008083,Child Mortality
C0871935,Theory
C0001790,Age-Specific Death Rate
C1521733,Pathologic
C0332298,Controlled by
C0242324,"Medicine, Modern"
C1853126,MOLECULAR BASIS
C0318356,Human virus
C1156245,Growth pattern
C3533081,Reporting rate
C4738108,Cumulative cases:Number:Point in time:^Event:Quantitative
C0205422,Sporadic (qualifier value)
C0557806,College
C0871939,time series
C0391871,Released (action)
C0205134,Curved
C2828360,Traverse
C3830550,December
C0949881,"Coronavirus OC43, Human"
C4698071,OC43
C1979874,Contrast
C1441526,Computed (procedure)
C0204514,Structural analysis
C0162807,"Protein Structure, Secondary"
C1135899,G+C Composition
C1179705,S2 innervation
C0439148,Unit
C1953353,Amino acid change
C1442161,Gene Deletion Abnormality
C0033204,Probability
C0221189,Jumping
C1875400,ISOLATE COMPOUND
C0205313,Original
C0242482,Summary Report
C0337664,Smoker
C1547647,Patient Outcome
C0184532,Dying Process
C4279946,Humanitarian Assistance
C1517001,Expected
C1444749,Exacerbated
C0231224,Crisis
C0079161,Infectious Disease Contact Tracing
C0035201,Resources
C0020405,Hygiene
C0018581,Handwashing
C0150269,Limit setting
C1524031,Minimum
C0038137,standards characteristics
C4505226,Gender-Based Violence
C0023124,Latrines
C1512173,Effectiveness of Interventions
C0949366,Vulnerable Populations
C0728831,Social
C0205749,"Factors, Economic"
C0025106,Medical Staff
C3898897,Helpful
C1948052,Now (temporal qualifier)
C0030231,Palliative Care
C0237400,Actual
C0949892,Ebolavirus
C0238606,West Africans
C0024501,Maintenance
C1282913,Circular
